Transitioning From M4 to Intern Year
Related Content
Oct 07, 2020
Kathryn Hawk, MD, MHS
Kathryn Hawk’s trailblazing research pushes the scientific boundaries of both emergency and addiction medicine by focusing on ED-initiated buprenorphine and linkage to treatment for opioid use disorder. She has worked to expand the implementation of best practices for ED patients with addictions nationwide and has been highly influential in driving the development of ACEP’s content and vision to improve the care of ED patients with OUD.
